Myeloperoxidase as a Marker of Hemodialysis Biocompatibility and Oxidative Stress: The Underestimated Modifying Effects of Heparin
- 31 January 2006
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 47 (1) , 37-41
- https://doi.org/10.1053/j.ajkd.2005.10.001
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranesNephrology Dialysis Transplantation, 2005
- Properties, Functions, and Secretion of Human MyeloperoxidaseBiochemistry (Moscow), 2004
- Myeloperoxidase in kidney diseaseKidney International, 2003
- Reassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyteJournal of Medical Microbiology, 2003
- New insights in dialysis membrane biocompatibility: relevance of adsorption properties and heparin bindingNephrology Dialysis Transplantation, 2003
- Reduction of Neutrophil Activation by Vitamin E Modified Dialyzer MembranesNephron, 2000
- Low polymorphonuclear cell degranulation during citrate anticoagulation: a comparison between citrate and heparin dialysisNephrology Dialysis Transplantation, 1997
- Plasma Levels of Main Granulocyte Components during HemodialysisAmerican Journal of Nephrology, 1990
- Plasma Levels of Main Granulocyte Components during Hemodialysis: Effects of ImmunosuppressionNephron, 1987
- Neutrophil and Eosinophil Degranulation during Hemodialysis Are Mediated by the Dialysis MembraneNephron, 1982